IRIS
SCANDURRA, GIUSEPPA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.039
AS - Asia 1.261
EU - Europa 673
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 33
OC - Oceania 4
Totale 4.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.976
SG - Singapore 423
BR - Brasile 277
IT - Italia 226
HK - Hong Kong 223
BD - Bangladesh 201
CN - Cina 158
IE - Irlanda 151
VN - Vietnam 134
DE - Germania 75
FR - Francia 55
GB - Regno Unito 42
AR - Argentina 40
CA - Canada 32
TR - Turchia 25
IN - India 24
MX - Messico 24
PL - Polonia 23
FI - Finlandia 18
NL - Olanda 17
EC - Ecuador 15
AT - Austria 13
ID - Indonesia 13
ZA - Sudafrica 13
IQ - Iraq 11
SE - Svezia 11
MA - Marocco 9
JP - Giappone 8
RU - Federazione Russa 8
SA - Arabia Saudita 7
UA - Ucraina 7
CO - Colombia 6
ES - Italia 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
KG - Kirghizistan 4
PY - Paraguay 4
BO - Bolivia 3
CH - Svizzera 3
KE - Kenya 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
SN - Senegal 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 4.367
Salva come PNG Salva come JPEG
Città #
Dallas 856
San Jose 230
Hong Kong 222
Singapore 208
Dublin 151
Ashburn 138
Chicago 76
The Dalles 76
Ho Chi Minh City 57
Beijing 56
Boardman 51
Santa Clara 47
New York 38
Los Angeles 28
Hanoi 25
Palermo 24
São Paulo 24
Warsaw 22
Milan 20
Munich 20
Frankfurt am Main 18
Istanbul 17
Assago 16
London 16
Mexico City 16
Rome 16
Helsinki 14
Atlanta 13
Rio de Janeiro 13
Buffalo 10
Council Bluffs 10
Hillsboro 10
Chennai 8
Belo Horizonte 7
Haiphong 7
Montreal 7
Quito 7
Amsterdam 6
Campinas 6
Düsseldorf 6
Fortaleza 6
Misilmeri 6
Naples 6
Seattle 6
Stockholm 6
Tokyo 6
Agrigento 5
Baghdad 5
Biên Hòa 5
Brooklyn 5
Catania 5
Charlotte 5
Dhaka 5
Jeddah 5
Johannesburg 5
Limburg an der Lahn 5
Manchester 5
Mumbai 5
Portsmouth 5
Reston 5
Salvador 5
San Francisco 5
Toronto 5
Brasília 4
Brno 4
Buenos Aires 4
Cagliari 4
Can Tho 4
Cologne 4
Curitiba 4
Guayaquil 4
Lauterbourg 4
Nuremberg 4
Orem 4
Phoenix 4
Secaucus 4
Ankara 3
Asunción 3
Bishkek 3
Cape Town 3
Caselle Torinese 3
Colombo 3
Da Nang 3
Erbil 3
Genoa 3
Jacksonville 3
Joinville 3
Montevideo 3
Nairobi 3
Porto Alegre 3
Três Lagoas 3
Turin 3
Turku 3
Varallo Pombia 3
Vienna 3
Zurich 3
Abu Dhabi 2
Angra dos Reis 2
Aparecida de Goiânia 2
Aracaju 2
Totale 2.833
Salva come PNG Salva come JPEG
Nome #
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 236
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 111
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 101
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 98
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 91
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 90
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 88
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 86
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 86
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study 83
Brain Metastasis in Endometrial Cancer: A Systematic Review 82
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 79
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 79
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 79
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 77
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center 77
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 71
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 70
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity 70
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 70
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status 68
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 67
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 66
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 64
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 64
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy 63
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 62
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial 61
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy 61
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 60
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 60
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 58
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 58
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 57
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report 56
Appropriate Management of Cutaneous Adverse Events Maximizes Compliance with Sorafenib Treatment: A Single-Center Experience 55
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 52
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 51
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? 51
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 50
The long survival in oncology: which QoL? Finding study in more than five years after the end of treatment 50
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma 50
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention 49
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy 49
Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 48
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial 48
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study 48
The group's waiting room: groups of self-help in oncology 48
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment 48
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 48
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 47
Syringoid eccrine carcinoma of the vulva: differential diagnosis, treatment, and follow-up 46
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 46
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 45
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study. 44
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 44
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 43
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 41
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 40
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study 40
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications 39
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience 39
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance 38
Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia 38
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 36
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 33
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice 33
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis 31
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 29
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen 28
The importance of planning a correct therapeutic strategy in patients with recurrent ovarian cancer. 25
Multidisciplinary team for elucidation of any new mutation and how this approach can be useful to individualize any genetic result: the case of BRCA2 c.631G>A/c.7008-2A>T genotype 25
A multidisciplinary approach and patient and caregiver education lead to improved prevention and rapid resolution of ocular adverse events in ovarian cancer patients treated with mirvetuximab soravtansine 22
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey 19
Gynecological Cancer Patient Perspectives On The Impact Of Illness And On Clinical Research Awareness: A MITO Group Nationwide Italian Survey 18
Beyond the Goal (Lens) towards new mental spaces. 14
Optimizing the management of peripherally inserted central catheter (PICC) 12
"Stay Stand" Project. Workshops in a Rugby field with cancer patients, their family and healthcare staff 11
Proper training of healthcare personnel helps to manage urgentemergency situations in an optimal way 10
Optimizing the management of therapies by providing a subcutaneous injection 9
Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study 8
Quality of life in southern Italian women with gynecological cancer. 8
Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue 7
Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With Cemiplimab 6
Magnesium and Cancer Immunotherapy: A Narrative Practical Review 5
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review 5
From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung Metastases 4
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial 4
Scientific Meetings in Medical Oncology: Are We Facing a Time- and Resource-Consuming Plethora? 4
Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? 4
Rethinking local therapy in de novo metastatic breast cancer: the emerging role of radiotherapy 1
Totale 4.495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 0 0 0 1 0
2023/2024213 1 2 13 10 24 16 34 21 14 18 26 34
2024/20251.049 40 17 30 8 61 131 110 100 127 153 149 123
2025/20263.128 186 519 574 269 138 86 189 248 249 189 309 172
2026/2027104 60 44 0 0 0 0 0 0 0 0 0 0
Totale 4.495